As the earnings season continues in full swing, investors need to follow the news in order to be awake to potential opportunities. On Tuesday, Curative Biotechnology Inc (OTCMKTS:CUBT) announced its financial results for the three-month period ended on March 31, 2021.
In this regard, it is also interesting to note that after the results were announced, the Curative Biotechnology stock remained unchanged. In the first quarter, the cash in hand soared to $564546 from only $160607.
However, perhaps more importantly, the company managed to reduce its debt to $75373 from $528893. That is a significant development for the company and one that could get the attention of plenty of investors going forward. Curative also announced that it converted both the Series A Preferred Shares and Series B Preferred Shares to common shares. While the stock remained flat on Tuesday, it remains to be seen if the stock experiences any movement over the coming days.